|
NCAPG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54979995503624E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84850040724416E-10 |
| Normal-vs-Stage2 |
1.741240E-03 |
| Normal-vs-Stage3 |
6.03299999999418E-05 |
| Normal-vs-Stage4 |
7.639000E-03 |
| Stage1-vs-Stage2 |
4.780800E-01 |
| Stage1-vs-Stage3 |
5.909400E-01 |
| Stage1-vs-Stage4 |
1.394800E-01 |
| Stage2-vs-Stage3 |
8.721800E-01 |
| Stage2-vs-Stage4 |
1.058160E-01 |
| Stage3-vs-Stage4 |
1.136760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6924000523797E-09 |
| Normal-vs-AfricanAmerican |
5.001400E-03 |
| Normal-vs-Asian |
1.509580E-01 |
| Caucasian-vs-AfricanAmerican |
1.897880E-02 |
| Caucasian-vs-Asian |
4.450400E-01 |
| AfricanAmerican-vs-Asian |
2.939000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8289038606365E-11 |
| Normal-vs-Female |
1.442880E-03 |
| Male-vs-Female |
7.759600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.817700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.79471999999237E-05 |
| Normal-vs-Age(61-80Yrs) |
1.34909999838229E-08 |
| Normal-vs-Age(81-100Yrs) |
2.352200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.028600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.072400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.837900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.460960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.920600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.145500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.211900E-04 |
| Normal-vs-Grade 2 |
2.26380025836193E-10 |
| Normal-vs-Grade 3 |
1.238000E-03 |
| Normal-vs-Grade 4 |
6.3159999999951E-05 |
| Grade 1-vs-Grade 2 |
8.765200E-01 |
| Grade 1-vs-Grade 3 |
9.447600E-01 |
| Grade 1-vs-Grade 4 |
3.874400E-01 |
| Grade 2-vs-Grade 3 |
7.852400E-01 |
| Grade 2-vs-Grade 4 |
2.106600E-01 |
| Grade 3-vs-Grade 4 |
4.592200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.95810004164099E-09 |
| Normal-vs-ccB subtype |
4.03969999673848E-08 |
| ccA subtype-vs-ccB subtype |
2.669600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.25150001262631E-09 |
| Normal-vs-N1 |
3.500800E-03 |
| N0-vs-N1 |
2.010200E-02 |
|
|
